GILEAD SCIENCES, INC. - 28 Jul 2022 Form 3 Insider Report for Allovir, Inc. (KLRS)

Role
10%+ Owner
Signature
Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson, Chief Financial Officer
Issuer symbol
KLRS
Transactions as of
28 Jul 2022
Net transactions value
$0
Form type
3
Filing time
05 Aug 2022, 17:45:47 UTC
Previous filing
17 Feb 2022
Next filing
28 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALVR Common Stock 13,704,416 28 Jul 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.